Trials / Completed
CompletedNCT02647905
Evaluation of the Accuracy of an Implanted Glucose Sensor
A Prospective, Multicenter Evaluation of the Accuracy of a Novel Continuous Implanted Glucose Sensor, PRECISE II
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Senseonics, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical investigation is to evaluate the accuracy of the Senseonics Continuous Glucose Monitoring System (Senseonics CGM System) measurements when compared with reference standard measurements The investigation will also evaluate safety of the Senseonics CGM System usage.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Continuous Glucose Monitoring System | Accuracy and safety assessment of a continuous glucose monitoring device |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2016-07-01
- Completion
- 2016-07-01
- First posted
- 2016-01-06
- Last updated
- 2018-06-06
- Results posted
- 2018-06-06
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02647905. Inclusion in this directory is not an endorsement.